Subtype‐specific patterns of tau pathology in Alzheimer’s and related disorders

Diana A. Hobbs, Stephanie Doering, Austin McCullough, Peter R Millar, Shaney Flores, Sarah Keefe, Aristeidis Sotiras, Tammie L.s. Benzinger, Gregory S. Day, Brian A. GordonAlzheimer 2024 · DOI

TL;DR

This study reveals distinct tau pathology patterns across different subtypes of Alzheimer's disease (AD), including Posterior Cortical Atrophy (PCA) and Logopenic Variant Primary Progressive Aphasia (lvPPA). These findings highlight the crucial roles of evolutionary expansion and cerebrovascular health in tau accumulation, suggesting that a deeper understanding of these subtype-specific neurobiological profiles could lead to more targeted diagnostic and therapeutic strategies.

What Problem Does This Paper Address?

Alzheimer's disease (AD) is a complex neurodegenerative disorder characterized by progressive cognitive decline. However, AD presents with significant heterogeneity, with atypical clinical presentations like Posterior Cortical Atrophy (PCA) and Logopenic Variant Primary Progressive Aphasia (lvPPA) exhibiting distinct symptom profiles and affected brain regions. PCA typically impacts the posterior parietal and occipital lobes, leading to visuospatial deficits, while lvPPA affects temporoparietal regions, causing language impairments. Understanding the underlying biological mechanisms that drive these different presentations is crucial for developing effective treatments. This paper aims to unravel the subtype-specific patterns of tau pathology in AD and its related disorders, exploring how these patterns correlate with various biological factors.

Methods

The researchers utilized 18F-AV-1451 tau-PET imaging to quantify tau deposition in the brains of participants. This imaging technique allows for the visualization and measurement of tau tangles, a key hallmark of AD pathology.

Beyond tau imaging, the study mapped nine other biological properties to the cortical surface:

  • Gene expression: Measured through principal component analysis (PC1).
  • Myelin mapping: Assessed using T1-weighted/T2-weighted (T1W/T2W) MRI ratios.
  • Cortical thickness: A standard measure of brain structure.
  • Sensorimotor association axis: Represents the functional organization of brain regions.
  • Evolutionary expansion: Quantifies the relative size of brain regions based on evolutionary history.
  • Cerebral blood flow (CBF): A measure of blood supply to the brain.
  • Cerebral blood volume (CBV): Another indicator of brain vascularization.
  • Cerebral metabolic rate of glucose (CMRglu): Reflects brain energy consumption.

To analyze the relationships between tau deposition and these biological properties, the researchers employed two primary statistical methods:

  • Correlation matrices: To identify pairwise associations between variables.
  • Generalized Linear Models (GLMs): To assess more complex relationships and control for potential confounders.

Datasets

The study utilized data from participants recruited through the Knight Alzheimer Disease Research Center (Knight ADRC). The datasets included:

  • AD dementia: 54 participants (25 female, mean age 75.23 ± 6.52).
  • PCA: 9 participants (8 female, mean age 62.78 ± 7.21).
  • lvPPA: 6 participants (2 female, mean age 66.33 ± 6.38).

No new benchmarks were introduced; the study evaluated existing biological measures against tau pathology in these well-defined clinical groups.

Key Insights and Ideas

  • Tau pathology is not monolithic: The study strongly suggests that tau accumulation follows distinct spatial patterns depending on the clinical subtype of AD. This challenges a one-size-fits-all view of AD pathology.
  • Evolutionary expansion is a key player: A significant positive association was found between evolutionary expansion patterns and tau accumulation across all studied groups (AD, PCA, and lvPPA). This implies that brain regions that have undergone greater evolutionary expansion might be particularly vulnerable to tau pathology.
  • Cerebrovascular health matters: The findings highlight a complex interplay between cerebrovascular health (CBF, CBV) and tau accumulation. Negative associations were observed between CBF and myelin mapping with tau in AD and lvPPA, suggesting that compromised vascular function might contribute to or be associated with tau buildup.
  • Gene expression and myelin are subtype-specific correlates: While gene expression showed a positive association with tau in PCA, it was negatively associated in AD. Similarly, myelin mapping showed negative associations with tau in AD and PCA. This indicates that the biological underpinnings of tau pathology can vary significantly between subtypes.
  • Cortical thickness and sensorimotor function are also involved: Negative associations were found between cortical thickness and sensorimotor association axis with tau in PCA, suggesting that structural integrity and functional organization in these areas are linked to tau pathology in this subtype.

Key Results

  • Positive associations with evolutionary expansion: Tau accumulation was positively correlated with evolutionary expansion in AD (r = 0.53), PCA (r = 0.29), and lvPPA (r = 0.56).
  • Gene expression in PCA: A significant positive association was observed between gene expression and tau accumulation in PCA (r = 0.51).
  • Negative associations with cerebrovascular health and myelin:
    • AD: Negative associations with CBF (r = -0.38) and myelin mapping (r = -0.15).
  • IvPPA: Negative associations with CBF (r = -0.18) and myelin mapping (r = -0.28).
  • Negative associations with cortical thickness and sensorimotor axis in PCA: (r = -0.25 and -0.23, respectively).
  • GLMs confirmed broader relationships: Generalized linear models demonstrated significant relationships between cerebrovascular health and evolutionary expansion with tau measures across all groups.
  • Subtype-specific gene expression and myelin associations: AD (r = -0.52) and PCA (r = -0.19) showed negative associations with gene expression and myelin mapping, respectively.
  • IvPPA and sensorimotor cortex: IvPPA (r = 0.39) displayed a positive association with the sensorimotor association cortex.

Limitations and Future Work

Limitations: * The sample sizes for PCA (n=9) and lvPPA (n=6) are relatively small, which may limit the generalizability of findings for these specific subtypes. * The study focuses on correlational relationships, and while GLMs help control for some factors, they do not establish definitive causality.

Future Work: * The authors suggest that these findings underscore the complex interplay of gene expression, myelin mapping, and cortical thickness with tau pathology. * Further research is needed to refine diagnostic and therapeutic strategies tailored to the distinct neurobiological profiles observed in AD, PCA, and lvPPA. This could involve developing imaging biomarkers or therapeutic targets that specifically address the unique pathological pathways in each subtype. * Investigating the causal mechanisms underlying these associations, particularly the role of evolutionary expansion and cerebrovascular health in tau propagation, is a promising avenue.

Summary updated

Abstract

Results elucidate distinct tau deposition patterns in AD, PCA, and lvPPA, providing insights into subtype-specific pathophysiology. The correlation matrix and GLMs highlight the significance of evolutionary expansion and cerebrovascular health in tau accumulation. Associations underscore the complex interplay of gene expression, myelin mapping, and cortical thickness with tau pathology. Findings contribute to understanding heterogeneity within AD spectrum disorders, emphasizing the multifaceted nature of neurodegenerative processes. Further research promises refined diagnostic and therapeutic strategies tailored to distinct neurobiological profiles in AD, PCA, and lvPPA.
BibTeX
@inproceedings{hobbs2024subtypespecific,
  author = {Diana A. Hobbs and Stephanie Doering and Austin McCullough and Peter R Millar and Shaney Flores and Sarah Keefe and Aristeidis Sotiras and Tammie L.S. Benzinger and Gregory S. Day and Brian A. Gordon},
  title = {{Subtype‐specific patterns of tau pathology in Alzheimer’s and related disorders}},
  booktitle = {Alzheimer},
  year = {2024},
  doi = {10.1002/alz.086138},
}
Figure